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Introduction
Colchicine is the main therapeutic drug which is used for
Familial Mediterranean Fever (FMF) and acute gout
attacks. In a limited study, the leucocyte colchicine level
has been implicated to be important for monitoring of drug
level. It will be important especially in the drug resistant
patients. Therefore, we aimed to investigate the usability of
different matrix for the monitoring of colchicine level.
Methods
We used Agilent model 6420 LC-MS/MS using electro-
spray ionization (ESI) to measure colchicine level. We
used whole blood as a specimen, first we obtained
plasma by centrifugation, second we collected leucocytes
using Ficoll-Hypaque, and the last we separated Ficoll
during leucocyte isolation. We added colchicine into
whole blood at a concentration that to obtain 10 ng/ml
final concentration. Tegafur was used as an internal
standard. We lysed leucocytes by TritonX (1/1000: v/v).
Colchicine was extracted from the all three matrix with
3 fold volume of the matrix of a dichloromethane/iso-
propanol/ethyl acetate mixture (1:1:3;v/v). After phase
separation by centrifugation, the organic layer was trans-
ferred and evaporated to dryness. The residue was
reconstituted with mobile phase and injected into LC-
MS/MS. LC flow rate of 0.5 ml, the phase gradient of
10 mM ammonium acetate + 0.1% formic acid+water
for phase A and the mixture consisted of 0.1% formic
acid in methanol for phase B were used.
Results
We found that colchicine levels of the three matrix were
correlated each other. However, the necessary volume of
plasma samples, 200 microlitre, was lower than Ficoll-
Hypaque solution (1 mL) which was used for leucocyte
separation. Plasma specimens seem more clear and sui-
table than serum specimens. Colchicine concentration
of leucocyte obtained from 1 mL of whole blood is
nearly half of plasma level. In addition, tegafur, IS, was
correlated with colchicine level well in all matrix.
Conclusion
We showed that plasma, Ficoll-Hypaque, and leucocyte
could be used for the monitoring of colchicine level in
patients. However, we do not know which matrix is the
best suited for the monitoring of colchicine level in
resistant patients. Therefore, further studies are needed
to clarify this point in a large patient population com-
prising resistant patients as well.
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